BVF raises stake in biopharma firm BioLineRx to 24.9 pct

* Israeli biopharmaceutical firm BioLineRx said onWednesday that BVF Partners, its largest shareholder, agreed toinvest an additional $9.6 million in BioLineRx, raising itsholding to 24.9 percent from 18.3 percent.
The post BVF raises stake in biopharma firm BioLineRx to 24.9 pct appeared first on RocketNews | Top News Stories From Around the Globe.